The mechanism of action of methotrexate

Rheumatic Disease Clinics of North America

Volumn 23, Issue 4, 1997, Pages 739-755

  Cronstein, B N ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIRHEUMATIC AGENT; DIHYDROFOLATE REDUCTASE; METHOTREXATE; POLYGLUTAMIC ACID;

ANTIINFLAMMATORY ACTIVITY; BIOCHEMISTRY; CELL PROLIFERATION; DRUG DESIGN; DRUG EFFICACY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; METHYLATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0030664737     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70358-6     Document Type: Article

References (106)

1. al-Awadhi A. P. Dale R.J. McKendry Pancytopenia associated with low-dose methotrexate therapy: A regional survey J Rheumatol 20 1993 1121 1125
2. G.S. Alarcon R.E. Schrohenloher A.A. Bartolucci Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis Arthritis Rheum 33 1990 1156 1161
3. C.J. Allegra J.C. Drake J. Jolivet Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates Proc Natl Acad Sci USA 82 1985 4881 4885
4. P.A. Anderson S.G. West J.R. O'Dell Weekly pulse methotrexate in rheumatoid arthritis: Clinical and immunologic effects in a randomized double-blind study Ann Intern Med 103 1985 489 496
5. J.E. Baggott W.H. Vaughn B.B. Hudson Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide Biochem J 236 1986 193 200
6. J. Barankiewicz R. Jimenez G. Ronlov Alteration of purine metabolism by AICA-riboside in human B lymphoblasts Arch Biochem Biophys 282 1990 377 385
7. J. Barankiewicz G. Ronlov R. Jimenez Selective adenosine release from human B but not T lymphoid cell line J Biol Chem 265 1990 15738 15743
8. P. Barrera A.M. Boerbooms R.W. Sauerwein Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity Lymphokine Cytokine Research 13 1994 155 159
9. P. Barrera C.J. Haagsma A.M.T. Boerbooms Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists: Longitudinal evaluation in patients with rheumatoid arthritis Br J Rheumatol 34 1995 747 755
10. J.C. Bernini D.W. Fort J.C. Griener Aminophylline for methotrexate-induced neurotoxicity Lancet 345 1995 544 547
11. M.G. Bouma R.K. Stad van den Wildenberg F.A.J.M. Differential regulatory effects of adenosine on cytokine release by activated human monocytes J Immunol 153 1994 4159 4168
12. M.G. Bouma van den Wildenberg F.A.J.M. W.A. Buurman Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells Am J Physiol 39 1996 522 529
13. D.L. Boyle F.G. Sajjadi G.S. Firestein Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation Arthritis Rheum 39 1996 923 930
14. M. Brody I. Bohm R. Bauer Mechanism of action of methotrexate: Experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells Europ J Clin Chem Clin Biochem 31 1993 667 674
15. B.A. Chabner C.J. Allegra G.A. Curt Polyglutamation of methotrexate: Is methotrexate a prodrug? J Clin Invest 76 1985 907 912
16. D.M. Chang P. Baptiste P.H. Schur The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes J Rheumatol 17 1990 1148 1157
17. B. Combe C. Didry M. Gutierrez Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis Eur J Med 2 1993 153 156
18. K.M. Connolly V.J. Stecher E. Danis Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate Int J Immunopharmacol 10 1988 717 728
19. A. Crilly I.B. McInness A.G. McDonald Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low-dose oral methotrexate J Rheumatol 22 1995 224 226
20. B.N. Cronstein M.A. Eberle H.E. Gruber Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells Proc Natl Acad Sci USA 88 1991 2441 2445
21. B.N. Cronstein S.B. Kramer G. Weissmann Adenosine: A physiological modulator of superoxide anion generation by human neutrophils J Exp Med 158 1983 1160 1177
22. B.N. Cronstein R.I. Levin J. Belanoff Adenosine: An endogenous inhibitor of neutrophil-mediated injury to endothelial cells J Clin Invest 78 1986 760 770
23. B.N. Cronstein R.I. Levin M.R. Philips Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors J Immunol 148 1992 2201 2206
24. B.N. Cronstein D. Naime G.S. Firestein The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine Arthritis Rheum 38 1995 1040 1045
25. B.N. Cronstein D. Naime E. Ostad The antiinflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation J Clin Invest 92 1993 2675 2682
26. B.N. Cronstein E.D. Rosenstein S.B. Kramer Adenosine, a physiologic modulator of superoxide anion generation by human neutrophils: Adenosine acts via an A2 receptor on human neutrophils J Immunol 135 1985 1366 1371
27. R.P. Dong J. Kameoka M. Hegen Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response J Immunol 156 1996 1349 1355
28. J.C. Fantone R.E. Duque B.H. Davis 3-Deaza-adenosine inhibition of stimulus–response coupling in human polymorphonuclear leukocytes J Leukoc Biol 45 1989 121 128
29. G.S. Firestein D. Boyle D.A. Bullough Protective effect of an adenosine kinase inhibitor in septic shock J Immunol 152 1994 5853 5859
30. G.S. Firestein M.M. Paine D.L. Boyle Mechanisms of methotrexate action in rheumatoid arthritis: Selective decrease in synovial collagenase gene expression Arthritis Rheum 37 1994 193 200
31. E. Flescher T.L. Bowlin A. Ballester Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis J Clin Invest 83 1989 1356 1362
32. E. Flescher T.L. Bowlin N. Talal Polyamine oxidation downregulates IL-2 production by human peripheral blood mononuclear cells J Immunol 142 1989 907 912
33. E. Flescher T.L. Bowlin N. Talal Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids Clin Exp Immunol 87 1992 435 437
34. Y. Furumitsu K. Yukioka A. Kojima Levels of urinary polyamines in patients with rheumatoid arthritis J Rheumatol 20 1993 1661 1665
35. P. Gadangi M. Longaker D. Naime The antiinflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites J Immunol 156 1996 1937 1941
36. H.E. Gruber M.E. Hoffer D.R. McAllister Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: Effects on flow, granulocytes and injury Circulation 80 1989 1400 1411
37. T. Ha S.L. Morgan W.H. Vaughan Inhibition of adenosine deaminase and S-adenosyl homocysteine hydrolase by 5-aminoimidazole-4-carboxamide riboside FASEB J 6 1992 1210 1215
38. J.S. Hawkes L.G. Cleland S.M. Proudman The effect of methotrexate on ex vivo lipoxygenase metabolism in neutrophils from patients with rheumatoid arthritis J Rheum 21 1994 55 58
39. M.S. Hershfield N.M. Krodich S-Adenosylhomocysteine hydrolase is an adenosine-binding protein: A target for adenosine toxicity Science 202 1978 757 760
40. M.S. Hershfield J. Kurtzberg V.N. Aiyar Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency Ann NY Acad Sci 451 1985 78 86
41. S.K. Hu Y.L. Mitcho A.L. Oronsky Studies on the effect of methotrexate on macrophage function J Rheumatol 15 1988 206 209
42. J.M. Johnston N.M. Kredich Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes J Immunol 123 1979 97 103
43. C.H. Jurgensen B.E. Huber T.P. Zimmerman 3-Deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor–stimulated human endothelial cells J Immunol 144 1990 653 661
44. C.H. Jurgensen G. Wolberg T.P. Zimmerman Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosine Agents Actions 27 1989 398 400
45. G.M. Kammer R.E. Birch S.H. Polmar Impaired immunoregulation in systemic lupus erythematosus: Defective adenosine-induced suppressor T lymphocyte generation J Immunol 130 1983 1706 1712
46. G.M. Kammer S.A. Rudolph Regulation of human T lymphocyte surface antigen mobility by purinergic receptors J Immunol 133 1984 3298 3302
47. G.M. Kammer J.A. Smith R. Mitchell Capping of human T-cell–specific determinants: Kinetics of capping and receptor re-expression and regulation by the cytoskeleton J Immunol 130 1983 38 44
48. P.J. Kerstens A.M. Boerbooms M.E. Jeurissen Accelerated nodulosis during low-dose methotrexate therapy for rheumatoid arthritis: An analysis of ten cases J Rheum 19 1992 867 871
49. N.M. Kredich Martin D.V. Jr Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cells Cell 12 1977 931 938
50. J.M. Kremer The mechanism of action of methotrexate in rheumatoid arthritis: the search continues J Rheumatol 21 1994 1 5
51. J.M. Kremer J. Galivan A. Streckfuss Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and formation of polyglutamates Arthritis Rheum 29 1986 832 835
52. J.M. Kremer W. Jubiz A. Michalek Fish-oil fatty acid supplementation in active rheumatoid arthritis: A double-blinded, controlled, crossover study Ann Intern Med 106 1987 497 503
53. J.M. Kremer D.A. Lawrence W. Jubiz Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis: Clinical and immunologic effects Arthritis Rheum 33 1990 810 820
54. J.M. Kremer C.T. Phelps Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months Arthritis Rheum 35 1992 138 145
55. T.A. Krenitsky J.L. Rideout E.Y. Chao Imidazol[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents J Med Chem 29 1986 138 143
56. E. Krump G. Lemay P. Borgeat Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo Br J Pharmacol 117 1996 1639 1644
57. J.K. Lacki K. Klama S.H. Mackiewicz Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: preliminary report Inflammation Research 44 1995 24 26
58. Le Moine O. P. Stordeur L. Schandene Adenosine enhances IL-10 secretion by human monocytes J Immunol 156 1996 4408 4414
59. E.J. Leonard A. Skeel P.K. Chiang The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes Biochem Biophys Res Commun 84 1978 102 109
60. J.L. Leroux M. Damon C. Chavis Effects of a single dose of methotrexate on 5- and 12-lipoxygenase products in patients with rheumatoid arthritis J Rheumatol 19 1992 863 866
61. M.E. Lesch M.A. Ferin C.D. Wright The effects of (R)-N-(1-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist on rat acute models of inflammation and neutrophil function Agents Actions 34 1991 25 27
62. A.L. Luhby J.H. Cooperman Aminoimidazole carboxamide excretion in vitamin B12 and folic acid deficiencies Lancet 2 1962 1381 1382
63. R. Mandler R.E. Birch S.H. Polmar Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus Proc Natl Acad Sci USA 79 1982 7542 7546
64. J.T. Merrill D. Coffey C. Shen Mechanisms of rheumatoid nodulosis: methotrexate-enhanced monocyte fusion requires protein synthesis and intact microtubules [Abstract] Arthritis Rheum 38 Suppl 1995 157
65. J.T. Merrill B.N. Cronstein C. Shen Reversal of new but not old rheumatoid nodules by colchicine: evidence from an in vitro model and case reports of 14 patients [Abstract] Arthritis Rheum 39 1996 240
66. J.T. Merrill J.A. Salmon D. Schreibman Mechanism of methotrexate-induced rheumatoid nodulosis: enhancement of adenosine release by monocytes in the process of granuloma formation Arthritis Rheum 39 1996 285
67. S.L. Morgan J.E. Baggott W.H. Vaughn Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trial Ann Intern Med 121 1994 833 841
68. S.L. Morgan J.E. Baggott W.H. Vaughn The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 33 1990 9 18
69. G. Nesher T.L. Moore The in vitro effects of methotrexate on peripheral blood mononuclear cells: Modulation by methyl donors and spermidine Arthritis Rheum 33 1990 954 959
70. G. Nesher T.L. Moore R.W. Dorner In vitro effects of methotrexate on peripheral blood monocytes: Modulation by folinic acid and S-adenosylmethionine Ann Rheum Dis 50 1991 637 641
71. M.E. Olah G.L. Stiles Adenosine receptor subtypes: Characterization and therapeutic regulation Annu Rev Pharmacol Toxicol 35 1995 581 606
72. N.J. Olsen G.P. Teal R.H. Brooks IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritis Agents Actions 34 1991 169 171
73. H. Osswald C. Gleiter B. Muhlbauer Therapeutic use of theophylline to antagonize renal effects of adenosine [review] Clin Nephrol 1 suppl 43 1995 33 37
74. M.J. Parmely Zhou W.-W. C.K. Edwards Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge J Immunol 151 1993 389 396
75. M.C. Pike N.M. Kredich R. Snyderman Requirement of S-adenosyl- l -methionine-mediated methylation for human monocyte chemotaxis Proc Natl Acad Sci USA 75 1978 3928 3932
76. S. Rosengren G.W. Bong G.S. Firestein Anti-inflammatory effects of an adenosine kinase inhibitor: Decreased neutrophil accumulation and vascular leakage J Immunol 154 1995 5444 5451
77. F.G. Sajjadi K. Takabayashi A.C. Foster Inhibition of TNFα expression by adenosine: Role of A3 adenosine receptors J Immunol 156 1996 3435 3442
78. D.J. Schrier M.E. Lesch C.D. Wright The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats J Immunol 145 1990 1874 1879
79. L.A. Schultz G.M. Kammer S.A. Rudolph Characterization of the human T lymphocyte adenosine receptor: Comparison of normal and systemic lupus erythematosus cells FASEB J 2 1988 244 250
80. R. Segal E. Mozes M. Yaron The effects of methotrexate on the production and activity of Il-1 Arthritis Rheum 32 1989 370 377
81. R. Segal E. Mozes M. Yaron The effects of methotrexate on the production and activity of interleukin-1 Arthritis Rheum 32 1989 370 377
82. R. Segal M. Yaron B. Tartakovsky Rescue of interleukin-1 activity by leucovorin following inhibition by methotrexate in a murine in vitro system Arthritis Rheum 33 1990 1745 1748
83. P. Seideman R. Muller-Suur E. Ekman Renal effects of low dose methotrexate in rheumatoid arthritis [Comments] J Rheumatol 20 1993 1126 1128
84. M. Seitz B. Dewald M. Ceska Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate Rheumatol Int 12 1992 159 164
85. D.M. Smith J.A. Johnson R.A. Turner Biochemical perturbations of BW 91Y (3-deazaadenosine) on human neutrophil chemotactic potential and lipid metabolism Intl J Tissue React 13 1991 1 18
86. T. Smith-Oliver L.S. Noel Elevated levels of TNF in the joints of adjuvant arthritic rats Cytokine 5 1993 298 304
87. R. Snyderman M.C. Pike N.M. Kredich Role of transmethylation reactions in cellular motility and phagocytosis Mol Immunol 17 1980 209 218
88. 4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate Arthritis Rheum 35 1992 376 384
89. R.I. Sperling J.S. Coblyn J.K. Larkin Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate Arthritis Rheum 33 1990 1149 1155
90. C.R. Stopford G. Wolberg K.L. Prus 3-Deazaadenosine-induced disorganization of macrophage microfilaments Proc Natl Acad Sci USA 82 1985 4060 4064
91. S.S.J. Sung S.C. Silverstein Inhibition of macrophage phagocytosis by methylation inhibitors: Lack of correlation of protein carboxymethylation and phospholipid methylation with phagocytosis J Biol Chem 260 1985 546 554
92. 2 receptors, adenosine inhibits production of tumor necrosis factor-α of endotoxin-stimulated polymorphonuclear leukocytes J Lab Clin Med 126 1995 275 282
93. 4 monoclonal antibody therapy in early rheumatoid arthritis Arthritis Rheum 38 1995 1097 1106
94. T.C. Wascher J. Hermann H.P. Brezinschek Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis Clin Invest 72 1994 535 540
95. T.C. Wascher J. Hermann R. Brezinschek Serum levels of interleukin-6 and tumour-necrosis-factor-alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low-dose methotrexate Europ J Clin Invest 24 1994 73 75
96. M.E. Weinblatt J.S. Coblyn D.A. Fox Efficacy of low-dose methotrexate in rheumatoid arthritis N Engl J Med 312 1985 818 822
97. M.E. Weinblatt P. Fraser Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy Arthritis Rheum 32 1989 1592 1596
98. M.E. Weinblatt D.E. Trentham P.A. Fraser Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis Arthritis Rheum 31 1988 167 175
99. A.S. Williams J.P. Camilleri N. Topley Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate J Pharmacol Toxicol Methods 32 1994 53 58
100. A.S. Williams Y.L. Punn N. Amos The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes Br J Rheumatol 34 1995 241 245
101. A.S. Williams N. Topley N. Amos Effect of three lipophilic methotrexate derivatives upon mediator release by lipopolysaccharide-stimulated rat peritoneal macrophages J Pharm Pharmacol 46 1994 291 295
102. A.S. Williams N. Topley B.D. Williams Effect of liposomally encapsulated MTX-DMPE conjugates upon TNF alpha and PGE2 release by lipopolysaccharide stimulated rat peritoneal macrophages Biochim Biophys Acta 1225 1994 217 222
103. K. Yukioka S. Wakitani M. Yukioka Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis J Rheumatol 19 1992 689 692
104. C.L. Zimmerman T.J. Franz J.T. Slattery Pharmacokinetics of the poly-gamma-glutamyl metabolites of methotrexate in skin and other tissues of rats and hairless mice J Pharmacol Exp Ther 231 1984 242 247
105. T.P. Zimmerman M. Iannone G. Wolberg 3-Deazaadenosine: S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes J Biol Chem 259 1984 1122 1126
106. T.P. Zimmerman G. Wolberg G.S. Duncan Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: Evidence for a methylation reaction essential for cytolysis Proc Natl Acad Sci USA 75 1978 6220 6224